CD154 Blockade for Induction of Mixed Chimerism and Prolonged Renal Allograft Survival in Nonhuman Primates-Reference-Cited by-同舟云学术

CD154 Blockade for Induction of Mixed Chimerism and Prolonged Renal Allograft Survival in Nonhuman Primates

Published:2004-09 Issue:9 Volume:4 Page:1391-1398
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Kawai Tatsuo,Sogawa Hiroshi,Boskovic Svetlan,Abrahamian Gregory,Smith Rex-Neal,Wee Siew-Lin,Andrews David,Nadazdin Ognjenka,Koyama Ichiro,Sykes Megan,Winn Henry J.,Colvin Robert B.,Sachs David H.,Cosimi A. Benedict

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2004.00523.x/fullpdf

Reference30 articles.

1. CD40-gp39 INTERACTIONS PLAY A CRITICAL ROLE DURING ALLOGRAFT REJECTION

2. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

3. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection

4. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

5. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40;American Journal of Transplantation;2024-08

2. Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulation;Frontiers in Immunology;2024-02-22

3. Combining Treg Therapy With Donor Bone Marrow Transplantation: Experimental Progress and Clinical Perspective;Transplantation;2023-10-04

4. The Future of Heart and Lung Transplantation;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

5. TNX-1500, a crystallizable fragment–modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival;American Journal of Transplantation;2023-08